GL1X · GenesisL1 explorer

MolNFT v1 · #140511 · protein

Crystal structure of schlafen 13 (SLFN13) N'-domain

5YD0 · Schlafen 8: “Crystal structure of schlafen 13 (SLFN13) N'-domain”. X-ray diffraction, 1 ligand (ZN), 15 pockets (best druggability 0.53). MolNFT v1 #140511 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5YD0
Type
protein
Length
1,300 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Schlafen 8
UniProt
Q5U311
Ligands
ZN
Pockets
15 · best druggability 0.53

Structure

x-ray diffraction · 4 distinct chains · 30% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASchlafen 8protein32731% helix, 24% strandQ5U311
BSchlafen 8protein33130% helix, 24% strandQ5U311
CSchlafen 8protein31628% helix, 21% strandQ5U311
DSchlafen 8protein32629% helix, 24% strandQ5U311

Ligands and binding sites

  • ZN · Zinc ion · metal · 4 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

15 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11570.530.8033empty
21830.500.7736empty
3600.440.8316empty
4750.440.8120empty
51270.430.7618empty

Interfaces

4 interfaces between chains.

  • C–D · 891 Ų buried · 8 hydrogen bonds · protein-protein
  • A–B · 839 Ų buried · 7 hydrogen bonds · protein-protein
  • B–D · 814 Ų buried · 9 hydrogen bonds · protein-protein
  • A–C · 792 Ų buried · 9 hydrogen bonds · protein-protein

Compared structures

  • 5YD0 · Crystal structure of Schlafen 13 (SLFN13) N'-domain · the same entry in another collection · chain D against D, TM-score 1.00
  • Q5U311 · AlphaFold monomer V2.0 prediction for schlafen family member 13 (Q5U311) · a predicted model of the same protein · chain A against A, TM-score 0.93

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.